BLC
DXCM icon

Brown, Lisle/Cummings’s DexCom DXCM Stock Holding History

Brown, Lisle/Cummings’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42K Buy
+36
New +$2.4K ﹤0.01% 823
2025
Q2 		– Sell
-3
Closed -$205 – 783
2025
Q1 		$205 Buy
+3
New +$245 ﹤0.01% 778

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown, Lisle/Cummings's DXCM Position: Q2 2026 in Review

Brown, Lisle/Cummings opened a new position in DexCom (DXCM) in Q2 2026: 36 shares worth $2.42K. The stake represents ﹤0.01% of the portfolio and ranks #823 among its holdings. This is a return to the name: Brown, Lisle/Cummings previously reported a position in DXCM as recently as Q1 2025.

Brown, Lisle/Cummings first reported a position in DXCM in Q1 2025 and has held it in 2 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Brown, Lisle/Cummings held 36 shares of DexCom worth $2.42K as of Q2 2026.
  • DexCom was a new Brown, Lisle/Cummings position in Q2 2026.
  • DexCom made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #823 holding.
  • Brown, Lisle/Cummings first reported a position in DexCom in Q1 2025 and has held it in 2 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.